Catheter Precision, Inc. Material Event - What Happened

Here is the latest news regarding Catheter Precision, Inc. (VTAK). I have removed the complex financial jargon so you can clearly understand these updates and what they mean for your portfolio.

1. What happened?

On April 15, 2026, shareholders voted to approve two major proposals that give the company more flexibility in how it manages its stock:

• Issuing more shares: The company is authorized to issue more common stock. This allows them to convert existing Series C, D, and E preferred stock into common shares, fulfilling legal promises made to institutional investors.
• Reverse Stock Split: The board now has the green light to perform a reverse stock split at a ratio between 1-for-2 and 1-for-100. The board will decide if and when to use this authority within the next year.

2. Why did it happen?

Catheter Precision, which develops the VIVO™ heart rhythm imaging system, is currently navigating a challenging financial period:

• Exchange Compliance: To stay listed on the NYSE American, the company must keep its share price above $1.00. A reverse split is a standard "mechanical" move used to artificially boost the share price to meet this requirement.
• Capital Obligations: The company must honor conversion rights held by private investors. Increasing the share count prevents a potential default and ensures they meet their contractual obligations.

3. Why does this matter to you?

This is essentially a "housekeeping" move to stabilize the company’s finances, but it comes with two specific risks:

• The Split: If the company executes a 1-for-50 split, an investor with 5,000 shares would end up with 100 shares. While the total value of your investment doesn't change, the market often views reverse splits as a sign of financial distress, which can lead to negative sentiment.
• The Share Issuance: This creates a risk of dilution. As the company converts debt into new shares, the total number of shares increases. This can lower the profit per share and reduce your overall ownership percentage in the company.

4. What happens next?

The board has the authority to act, but they are not required to do so immediately. They may wait to see if the stock price rises naturally before choosing to trigger a split. Keep an eye out for future filings that will confirm the specific ratio and the effective date if they decide to move forward.

5. Key takeaways for investors

• Focus on the business, not just the math: A reverse split is a mechanical change. It does not change the company’s core business, its medical technology, or its potential to sell the VIVO™ system.
• Watch for dilution: Because the company is issuing more shares, you should monitor whether their revenue growth can keep up. If the number of shares grows faster than the company’s earnings, the stock price may face downward pressure.
• Stay informed: If a split occurs, your brokerage will update your account automatically. Just be sure to update your personal records so you can accurately track your cost basis and performance.

Disclaimer: I am an AI, not a financial advisor. This summary is for informational purposes only and is not professional investment advice. Always do your own research before trading.